A Prospective Study on the Prediction Model of Para-aortic Lymph Node Metastasis
NCT06068387 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 264
Last updated 2023-10-10
Summary
The goal of this prospective single-arm trial is to investigate the accuracy and feasibility of the para-aortic lymph node metastasis prediction model in locally advanced cervical cancer, as well as its impact on patients' prognosis. The main questions it aims to answer are:
* Is the para-aortic lymph node metastasis prediction model accurate and feasible?
* Whether the para-aortic lymph node metastasis prediction model can affect the prognosis of patients.
Conditions
- Locally Advanced Cervical Cancer
Interventions
- PROCEDURE
-
surgical staging
para-aortic lymphadenectomy from the inferior mesenteric artery cranially to the aorta caudally via laparoscopy or laparotomy
Sponsors & Collaborators
-
Chongqing University Cancer Hospital
lead OTHER
Principal Investigators
-
Dongling Zou, M.D. · Chongqing University Cancer Hospital
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-01
- Primary Completion
- 2025-02-28
- Completion
- 2026-02-28
Countries
- China
Study Locations
More Related Trials
-
A Real-world Study of the Efficacy and Safety of PD-1 Inhibitors Combined With Chemoradiotherapy in Lung Metastatic Nasopharyngeal Carcinoma
NCT07062484 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Individualized Elective Neck Irradiation Based on MRI in NPC Patients
NCT02642107 ·Status: COMPLETED ·Phase: PHASE3
-
Sentinel Lymph Node Biopsy Versus Pelvic Lymphadenectomy in Early-stage Cervical Cancer (PHENIX/CSEM 010)
NCT02642471 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Surgery Alone Verus Sugery Combined with Dose-reduced Radiotherapy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma
NCT06688760 ·Status: RECRUITING ·Phase: NA
-
SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx
NCT06611137 ·Status: RECRUITING ·Phase: PHASE2
-
Neoadjuvant Chemotherapy Combined With PD-1 + Radical Radiotherapy in Locally Advanced Cervical Cancer
NCT05554276 ·Status: RECRUITING ·Phase: PHASE2
-
Chemotherapy Combined With Radiotherapy vs Chemotherapy Alone for Distant Metastatic Nasopharyngeal Carcinoma
NCT02111460 ·Status: UNKNOWN ·Phase: PHASE3
-
To Study the Feasibility and Quality of Life of Medial Group Retropharyngeal Node Sparing in Nasopharyngeal Carcinoma
NCT03346109 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Efficacy for Sentinel Lymph Node Policy in Intermediate-risk Endometrial Carcinomas
NCT03677024 ·Status: WITHDRAWN ·Phase: NA
-
A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients
NCT04061278 ·Status: UNKNOWN ·Phase: PHASE3
-
Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Non-small Cell Lung Cancer
NCT01054482 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Anti-PD-1 Combined With Albumin-Bound Paclitaxel in Patients With Recurrent Cervical Cancer
NCT04341883 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Therapy of GP Chemotherapy Combined With Tislelizumab in Locoregionally Advanced NPC
NCT04833257 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCC
NCT06699498 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma
NCT05340270 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Treating Locally Advanced Head and Neck Malignant Tumor With Anlotinib and Chemoradiotherapy
NCT04507035 ·Status: UNKNOWN ·Phase: PHASE4
-
Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases in NSCLC
NCT04912128 ·Status: COMPLETED
-
Retrospective Investigation of the Impacts of Prognosis for Nasopharyngeal Carcinoma Patients
NCT02604472 ·Status: COMPLETED
-
Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy
NCT07328841 ·Status: RECRUITING ·Phase: PHASE3
-
Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial
NCT05340491 ·Status: RECRUITING ·Phase: PHASE3
-
Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy
NCT06092957 ·Status: RECRUITING ·Phase: PHASE3
-
Tislelizumab Combined APF Chemotherapy in the Treatment of Locally Advanced Head and Neck Tumors
NCT05758389 ·Status: RECRUITING ·Phase: PHASE2
-
Individualized Neck Cervical Irradiation Prophylaxis Trial of NPC
NCT07303023 ·Status: RECRUITING ·Phase: PHASE3
-
A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma
NCT06157827 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Neoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002)
NCT04807140 ·Status: RECRUITING ·Phase: PHASE2